Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP664664.RAmAENnGJc57W8UYoEqXo5c2FiMU0GMqTvhUubjBKqfiU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP664664.RAmAENnGJc57W8UYoEqXo5c2FiMU0GMqTvhUubjBKqfiU130_assertion type Assertion NP664664.RAmAENnGJc57W8UYoEqXo5c2FiMU0GMqTvhUubjBKqfiU130_head.
- NP664664.RAmAENnGJc57W8UYoEqXo5c2FiMU0GMqTvhUubjBKqfiU130_assertion description "[Flavopiridol synergizes with sorafenib to induce cytotoxicity and potentiate antitumorigenic activity in EGFR/HER-2 and mutant RAS/RAF breast cancer model systems.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP664664.RAmAENnGJc57W8UYoEqXo5c2FiMU0GMqTvhUubjBKqfiU130_provenance.
- NP664664.RAmAENnGJc57W8UYoEqXo5c2FiMU0GMqTvhUubjBKqfiU130_assertion evidence source_evidence_literature NP664664.RAmAENnGJc57W8UYoEqXo5c2FiMU0GMqTvhUubjBKqfiU130_provenance.
- NP664664.RAmAENnGJc57W8UYoEqXo5c2FiMU0GMqTvhUubjBKqfiU130_assertion SIO_000772 23908594 NP664664.RAmAENnGJc57W8UYoEqXo5c2FiMU0GMqTvhUubjBKqfiU130_provenance.
- NP664664.RAmAENnGJc57W8UYoEqXo5c2FiMU0GMqTvhUubjBKqfiU130_assertion wasDerivedFrom befree-20150227 NP664664.RAmAENnGJc57W8UYoEqXo5c2FiMU0GMqTvhUubjBKqfiU130_provenance.
- NP664664.RAmAENnGJc57W8UYoEqXo5c2FiMU0GMqTvhUubjBKqfiU130_assertion wasGeneratedBy ECO_0000203 NP664664.RAmAENnGJc57W8UYoEqXo5c2FiMU0GMqTvhUubjBKqfiU130_provenance.